OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 75.8
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 25
CFR/IFR denominator: 33
Epidemic phase: Mid outbreak
Population group: Other
Sample type: Hospital based
Sex: Both
Sample size: 33
Country: Hong Kong SAR,  China
Location: Princess Margaret Hospital
Study period: 26 Feb-02 2003 to 31 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Unit: Days
Value type: Other
Lower bound: 1
Upper bound: 11
Bounds: 1 - 11
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Contact based
Sex: Both
Minimum age: 35
Maximum age: 72
Sample size: 10
Country: Hong Kong SAR,  China
Location: Queen Mary Hospital, Kwong Wah Hospital,
and Pamela Youde Nethersole Eastern Hospital
Study period: 22 Feb-02 2003 to 22 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 5
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 3
Uncertainty upper value: 7
Combined uncertainty: 3 - 7 (Range)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Contact based
Sex: Both
Minimum age: 35
Maximum age: 72
Sample size: 10
Country: Hong Kong SAR,  China
Location: Queen Mary Hospital, Kwong Wah Hospital,
and Pamela Youde Nethersole Eastern Hospital
Study period: 22 Feb-02 2003 to 22 Mar-03 2002
Other delay start: Symptom Onset/Fever
Other delay end: Other: dyspnea
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Contact based
Sex: Male
Minimum age: 53
Maximum age: 64
Sample size: 2
Country: Hong Kong SAR,  China
Study period: 22 Feb-02 2003 to 22 Mar-03 2002
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Contact based
Sex: Both
Minimum age: 35
Maximum age: 72
Sample size: 10
Country: Hong Kong SAR,  China
Study period: 22 Feb-02 2003 to 22 Mar-03 2002
Other delay start: Symptom Onset/Fever
Other delay end: Other: treatment
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 12.04
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 33.17
Bounds: 0 - 33.17
Uncertainty type: 95% CI
Uncertainty lower value: 10.11
Uncertainty upper value: 14.18
Combined uncertainty: 10.11 - 14.18 (95% CI)
CFR/IFR numerator: 124
CFR/IFR denominator: 1030
Epidemic phase: Post outbreak
Disaggregated by: Age
Population group: General population
Sample type: Community based
Sex: Both
Sample size: 2854
Country: Taiwan,  China
Location: San-Ming district of Kaoohsiung City
Study period:  Aug-08 2003 to  Dec-12 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 0.19
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 0.49
Bounds: 0 - 0.49
Uncertainty type: 95% CI
Uncertainty lower value: 0.02
Uncertainty upper value: 0.7
Combined uncertainty: 0.02 - 0.7 (95% CI)
CFR/IFR numerator: 2
CFR/IFR denominator: 1030
Epidemic phase: Post outbreak
Disaggregated by: Age
Population group: General population
Sample type: Community based
Sex: Both
Sample size: 2854
Country: Taiwan,  China
Location: San-Ming district of Kaoohsiung City
Study period:  Aug-08 2003 to  Dec-12 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 0.14
Unit: Percentage (%)
CFR/IFR denominator: 1453
Population group: General population
Sample type: Mixed settings
Sex: Unspecified
Sample size: 1453
Country: China, Hong Kong SAR,  China
Location: Guangdong Province, Hongkong, Macao, Peking, Guangzhou
Study period:  Jun-06 2003 to  Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 39.8
Upper bound: 100
Bounds: 39.8 - 100
Disaggregated by: Time
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Country: China
Location: Guangzhou and Peking
Study period:  Feb-02 2003 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 34.8
Upper bound: 100
Bounds: 34.8 - 100
Disaggregated by: Time
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Country: China
Location: Guangzhou and Peking
Study period:  Feb-02 2003 to  Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Unit: Percentage (%)
Lower bound: 18.5
Upper bound: 66.7
Bounds: 18.5 - 66.7
Disaggregated by: Other
Population group: Persons under investigation
Sample type: Contact based
Sex: Unspecified
Sample size: 77
Country: China
Location: Beijing
Study period: 5 Feb-02 2003 to 4 May-05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 20
Unit: Percentage (%)
Lower bound: 18
Upper bound: 23
Bounds: 18 - 23
CFR/IFR method: Unspecified
Disaggregated by: Disease generation
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 77
Country: China
Location: Beijing
Study period: 5 Feb-02 2003 to 4 May-05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5.7
Unit: Days
Value type: Mean
Epidemic phase: Unspecified
Risk factor: Close contact
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 33
Country: China
Location: Beijing
Study period: 5 Feb-02 2003 to 4 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Disaggregated by: Disease generation
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 77
Country: China
Location: Beijing
Study period: 5 Feb-02 2003 to 4 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Sex
Risk factor outcome: Superspreading
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 77
Country: China
Location: Beijing
Study period: 5 Feb-02 2003 to 4 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Close contact
Risk factor outcome: Superspreading
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 77
Country: China
Location: Beijing
Study period: 5 Feb-02 2003 to 4 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 254
Country: Hong Kong SAR,  China
Location: Hong Kong hospitals
Study period: 15 Mar-03 2003 to 24 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 0
Unit: Percentage (%)
CFR/IFR numerator: 0
CFR/IFR denominator: 398
CFR/IFR method: Naive
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Minimum age: 0
Maximum age: 91
Sample size: 398
Country: United States
Location: United States (national surveillance)
Study period: 17 Mar-03 2003 to 30 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 1
Uncertainty upper value: 14
Combined uncertainty: 1 - 14 (Range)
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 90
Country: United States
Location: United States (national surveillance)
Study period: 17 Mar-03 2003 to 30 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 4.587436164
Unit: No units
Epidemic phase: Start outbreak
Reproduction number method: Next generation matrix
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: Canada, Hong Kong SAR,  China
Location: Toronto, Hong Kong
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.7
Unit: No units
Value type: Unspecified
Lower bound: 2.7
Upper bound: 3.4
Bounds: 2.7 - 3.4
Uncertainty type: 95% CI
Uncertainty lower value: 2.2
Uncertainty upper value: 3.7
Combined uncertainty: 2.2 - 3.7 (95% CI)
Epidemic phase: Start outbreak
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Population group: Mixed groups
Sample type: Mixed settings
Sample size: 1512
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period: 3 Mar-03 2003 to 6 May-05 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Value type: Unspecified
Lower bound: 0.14
Upper bound: 1
Bounds: 0.14 - 1
Disaggregated by: Time
Population group: Mixed groups
Sample type: Mixed settings
Sample size: 1512
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period: 3 Mar-03 2003 to 6 May-05 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: beta - per capita contact rate per unit of time
Parameter value: 0.062
Unit: Unspecified
Value type: Other
Epidemic phase: Start outbreak
Population group: Mixed groups
Sample type: Mixed settings
Sample size: 1512
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period: 3 Mar-03 2003 to 6 May-05 2003
Pathogen: SARS-CoV
Parameter class: Overdispersion
Parameter type: Overdispersion
Parameter value: 331
Unit: Max. nr. of cases superspreading (related to case)
Value type: Other
Uncertainty type: 95% CI
Uncertainty lower value: 295
Uncertainty upper value: 331
Combined uncertainty: 295 - 331 (95% CI)
Epidemic phase: Mid outbreak
Sample type: Housing estate based
Sample size: 331
Country: Hong Kong SAR,  China
Location: Amoy Gardens
Study period: 18 Mar-03 2003 to 20 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Hospitalisation
Risk factor outcome: Other
Risk factor significance: Unspecified
Risk factor adjustment: Unspecified
Population group: Mixed groups
Sample type: Mixed settings
Sample size: 1512
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period: 3 Mar-03 2003 to 6 May-05 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Parameter value: 18.7
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 100
Bounds: 0 - 100
Epidemic phase: Mid outbreak
Disaggregated by: Occupation
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 193
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to 24 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 22
Upper bound: 50
Bounds: 22 - 50
CFR/IFR method: Unspecified
Epidemic phase: Mid outbreak
Disaggregated by: Occupation
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to 24 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 29
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 0
Upper bound: 100
Bounds: 0 - 100
CFR/IFR numerator: 36
CFR/IFR denominator: 124
Epidemic phase: Mid outbreak
Disaggregated by: Occupation
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 124
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to 24 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Close contact;Occupation
Risk factor outcome: Infection
Risk factor occupation: Healthcare;Other
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 193
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to 24 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Close contact;Occupation;Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare;Other
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 193
Country: Vietnam
Location: Hanoi
Study period: 26 Feb-02 2003 to 24 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 0.7
Unit: Percentage (%)
Uncertainty type: 95% CI
Uncertainty lower value: 0.54
Uncertainty upper value: 0.9
Combined uncertainty: 0.54 - 0.9 (95% CI)
Epidemic phase: Unspecified
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Unit: Percentage (%)
Lower bound: 0.42
Upper bound: 1.68
Bounds: 0.42 - 1.68
Epidemic phase: Unspecified
Disaggregated by: Age
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Unit: Percentage (%)
Lower bound: 0
Upper bound: 10.36
Bounds: 0 - 10.36
Epidemic phase: Unspecified
Disaggregated by: Level of exposure
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Unit: Percentage (%)
Lower bound: 0.68
Upper bound: 0.72
Bounds: 0.68 - 0.72
Epidemic phase: Unspecified
Disaggregated by: Sex
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Unit: Percentage (%)
Lower bound: 0.39
Upper bound: 2.45
Bounds: 0.39 - 2.45
Epidemic phase: Unspecified
Disaggregated by: Other
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Unit: Percentage (%)
Lower bound: 0.25
Upper bound: 0.88
Bounds: 0.25 - 0.88
Epidemic phase: Unspecified
Disaggregated by: Time
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Close contact;Other
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Sex
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 8662
Country: Canada
Location: Greater Toronto Area
Study period: 23 Feb-02 2003 to 2 Jul-07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 624
Country: Canada
Location: Toronto
Study period: 5 Mar-03 2003 to 12 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 624
Country: Canada
Location: Toronto
Study period: 5 Mar-03 2003 to 12 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 624
Country: Canada
Location: Toronto
Study period: 5 Mar-03 2003 to 12 Jun-06 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 3
Upper bound: 6.1
Bounds: 3 - 6.1
Epidemic phase: Mid outbreak
Disaggregated by: Age, Occupation, Symptoms
Population group: Mixed groups
Sample type: Mixed settings
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period:  Mar-03 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 0.8
Unit: Percentage (%)
Value type: Unspecified
Epidemic phase: Mid outbreak
Disaggregated by: Age, Occupation, Symptoms
Population group: Mixed groups
Sample type: Mixed settings
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period:  Mar-03 2003 to  May-05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 15
Unit: Percentage (%)
CFR/IFR numerator: 8
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 26 Mar-03 2003 to 25 May-05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 47
Unit: Percentage (%)
CFR/IFR numerator: 8
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 26 Mar-03 2003 to 25 May-05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 6
Unit: Days
Value type: Median
Lower bound: 1
Upper bound: 30
Bounds: 1 - 30
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 29
Maximum age: 76
Sample size: 8
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 26 Mar-03 2003 to 25 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Cormobidity;Other
Risk factor outcome: Death
Risk factor significance: Unspecified
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 29
Maximum age: 76
Sample size: 8
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 26 Mar-03 2003 to 25 May-05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Infection
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 47
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Close contact
Risk factor outcome: Infection
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 47
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Attack rate
Parameter type: Attack rate
Parameter value: 23.1
Unit: Percentage (%)
Lower bound: 5
Upper bound: 37
Bounds: 5 - 37
Epidemic phase: Post outbreak
Disaggregated by: Other
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 65
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 100
Unit: Percentage (%)
Epidemic phase: Post outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 15
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 6
Combined uncertainty: 2 - 6 (Range)
Epidemic phase: Post outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 11
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 4 Mar-03 2003 to 10 Mar-03 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 19.5
Unit: Days
Value type: Median
Lower bound: 13
Upper bound: 25
Bounds: 13 - 25
Epidemic phase: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 7
Country: Canada
Location: Greater Toronto Area
Study period: 23 Mar-03 2003 to
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5
Unit: Days
Value type: Median
Lower bound: 3
Upper bound: 8
Bounds: 3 - 8
Uncertainty type: Range
Uncertainty lower value: 1
Uncertainty upper value: 15
Combined uncertainty: 1 - 15 (Range)
Epidemic phase: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 7
Country: Canada
Location: Greater Toronto Area
Study period: 23 Mar-03 2003 to